MedTrace Logo

Adding Ujjayi Pranayama to Osteopathic Manipulative Treatment on Pulmonary Functions and Functional Capacity in College Students With Upper Cross Syndrome

NCT07052552 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-11-19

No results posted yet for this study

Summary

With the advent of the Internet, mobile phones and other electronic devices have become an integral component in everyone's lives, especially students, whether it is to attend classes, make purchases, conduct transactions, or have social interactions . The continuous use of these electronic devices can easily result in abnormal postures . Upper crossed syndrome (UCS) is one of the most frequently cited complications with modern technological life, which is characterized by weakened middle and lower trapezius, scalenes, deep cervical flexors and serratus anterior at the same time as the rhomboids, as well as tightness in the upper trapezius, pectoralis minor and major and levator scapulae muscles . It mainly leads to muscle imbalances, which eventually manifest in both tonic and phasic muscles

Conditions

  • Osteopathic Manipulation
  • Ujjayi Pranayama
  • Upper Cross Syndrome

Interventions

OTHER

osteopathic manipulative tratment only

focuses on restoring proper muscle balance and joint mechanics through techniques that address the shortened, tight muscles and the lengthened, weak muscles characteristic of the syndrome

OTHER

ujjayi pranayama and osteopathic manipulative treatment

Ujjayi pranayama, often called "ocean breath," can be a helpful practice for individuals with Upper Cross Syndrome (UCS) by promoting relaxation and improving breath control. While not a direct cure, it can alleviate some symptoms and improve overall posture and body awareness. Osteopathic manipulative treatment focuses on restoring proper muscle balance and joint mechanics through techniques that address the shortened, tight muscles and the lengthened, weak muscles characteristic of the syndrome

Sponsors & Collaborators

  • Al-Zaytoonah University of Jordan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
29 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-01
Primary Completion
2025-09-30
Completion
2025-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07052552 on ClinicalTrials.gov